Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Relation of ASXL2 Gene Mutation with Clinical Characteristics, Prognosis and C-KIT Gene Mutation in AML Patients with AML1- ETO Fusion Gene].

Zhongguo shi yan xue ye xue za zhi - 1 Feb 2020

Cui Peng, Xu Dong, Xing Tian, Ren Guo-Hua, Ma Shang-Min

Abstract excerpt

OBJECTIVE: To analyze relation of ASXL2 gene mutation with the clinical characteristics, prognosis and C-KIT gene mutation in acute myeloid leukemia (AML) patients with AML1-ETO fusion gene. METHODS: The clinical data of 63 primary AML patients with AML1-ETO fusion gene were collected and retrospectively analyzed. The mutation of ASXL2 gene was directly sequenced by PCR. The clinical characteristics, C-KIT...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Core Binding Factor Alpha 2 Subunit
Share to Leukemia, Myeloid, Acute

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Oncogene Proteins, Fusion

Share to Prognosis

Share to Proto-Oncogene Proteins c-kit

Share to Repressor Proteins

Share to RUNX1 Translocation Partner 1 Protein

Source

Identifiers

PMID: 32027264
DOI: 10.19746/j.cnki.issn.1009-2137.2020.01.021

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Relation of ASXL2 Gene Mutation with Clinical Characteristics, Prognosis and C-KIT Gene Mutation in AML Patients with AML1- ETO Fusion Gene].PMID 32027264Read ↗

[Frequency and clinical features of ASXL2 gene mutation in acute myeloid leukemia patients with AML1- ETO fusion gene positive].Semantic proximity Read ↗

[C-kit mutation in acute myeloid leukemia patients with AML1-ETO fusion gene and its clinical significance].Semantic proximity Read ↗

[Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with ASXL1 Gene Mutation].Semantic proximity Read ↗

Gene mutation profile and risk stratification in AML1‑ETO‑positive acute myeloid leukemia based on next‑generation sequencing.Semantic proximity Read ↗

[The Relationship between ASXL2 and ZBTB7A Gene Mutations and Prognosis in Patients with Acute Myeloid Leukemia].Semantic proximity Read ↗

Clinical characteristics and prognosis analysis of patients with de novo ASXL1-mutated AML treated with the C-HUNAN-AML-15 protocol: A multicenter study by the South China Pediatric AML Collaborative Group.Semantic proximity Read ↗

[Clinical Characteristics and Prognosis of U2AF1 Mutation in Patients with Acute Myeloid Leukemia].Semantic proximity Read ↗

[Clinical features and survival analysis in non-M(3) acute myeloid leukemia patients with ASXL1 gene mutation].Semantic proximity Read ↗

ASXL1 mutations in myeloid neoplasms: pathogenetic considerations, impact on clinical outcomes and survival.Semantic proximity Read ↗

A Case of AML1/ETO Positive Child with Acute Myeloid Leukemia with Poor Prognosis.Semantic proximity Read ↗

The characteristics and clinical prognosis analysis of ASXL1 mutations in Chinese adult patients with primary cytogenetically normal acute myeloid leukemia by next-generation sequencing.Semantic proximity Read ↗

[Pathophysiology of hematological malignancies associated with ASXL1 mutations].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.